FDA Kicks Off BsUFA III Talks

Public Meeting Scheduled Ahead Of Reauthorization From 2023 Till 2027

 
• By Akriti Seth
  
Agenda
The US FDA sets BsUFA III meeting agenda • Source: Shutterstock

More from Biosimilars

More from Products